3nnx: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
[[Image:3nnx.png|left|200px]] | [[Image:3nnx.png|left|200px]] | ||
{{STRUCTURE_3nnx| PDB=3nnx | SCENE= }} | {{STRUCTURE_3nnx| PDB=3nnx | SCENE= }} | ||
===Crystal structure of phosphorylated P38 alpha in complex with DP802=== | ===Crystal structure of phosphorylated P38 alpha in complex with DP802=== | ||
{{ABSTRACT_PUBMED_20800479}} | {{ABSTRACT_PUBMED_20800479}} | ||
==About this Structure== | ==About this Structure== | ||
[[3nnx]] is a 1 chain structure of [[Mitogen-activated protein kinase]] with sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NNX OCA]. | |||
==See Also== | |||
*[[Mitogen-activated protein kinase|Mitogen-activated protein kinase]] | |||
==Reference== | ==Reference== | ||
<ref group="xtra">PMID: | <ref group="xtra">PMID:020800479</ref><references group="xtra"/> | ||
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Mitogen-activated protein kinase]] | [[Category: Mitogen-activated protein kinase]] | ||
| Line 29: | Line 20: | ||
[[Category: Kinase]] | [[Category: Kinase]] | ||
[[Category: Transferase]] | [[Category: Transferase]] | ||
Revision as of 15:47, 27 July 2012
Crystal structure of phosphorylated P38 alpha in complex with DP802Crystal structure of phosphorylated P38 alpha in complex with DP802
Template:ABSTRACT PUBMED 20800479
About this StructureAbout this Structure
3nnx is a 1 chain structure of Mitogen-activated protein kinase with sequence from Homo sapiens. Full crystallographic information is available from OCA.
See AlsoSee Also
ReferenceReference
- ↑ Ahn YM, Clare M, Ensinger CL, Hood MM, Lord JW, Lu WP, Miller DF, Patt WC, Smith BD, Vogeti L, Kaufman MD, Petillo PA, Wise SC, Abendroth J, Chun L, Clark R, Feese M, Kim H, Stewart L, Flynn DL. Switch control pocket inhibitors of p38-MAP kinase. Durable type II inhibitors that do not require binding into the canonical ATP hinge region. Bioorg Med Chem Lett. 2010 Oct 1;20(19):5793-8. Epub 2010 Aug 3. PMID:20800479 doi:10.1016/j.bmcl.2010.07.134